<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Major causes of short stature</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Major causes of short stature</h1>
<div class="graphic"><div class="figure"><div class="ttl">Major causes of short stature</div><div class="cntnt"><table cellspacing="0"><colgroup span="6" width="16%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Distinguishing features</td> <td class="subtitle1">Typical evaluation</td> <td class="subtitle1">Treatment</td> <td class="subtitle1">Bone age</td> <td class="subtitle1">Height velocity</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Normal variants of growth</td> </tr> <tr> <td class="indent1">Familial short stature<sup>*</sup></td> <td>Short parent(s), often below the 10<sup>th</sup> percentile. Adult height short for population but within the range predicted by parents' height.</td> <td>Hx, PE, bone age.</td> <td>None needed. Reassurance; monitor growth.</td> <td>Normal</td> <td> <p>Low-normal</p> Eg, from age 6 until puberty: <ul class="decimal_heading"> <li>Girls approximately 4 to 5 cm/year</li> <li>Boys approximately 3.5 to 4.5 cm/year</li> </ul> </td> </tr> <tr> <td class="indent1">Constitutional delay of growth and puberty<sup>*</sup></td> <td>Normal height for bone age but not for chronologic age. Often, family history of delayed growth and/or puberty. Adult height usually normal.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>Be alert for the possibility of underlying systemic disease</li> <li>Laboratory screening if height velocity is slow</li> </ul> </td> <td>None needed. Reassurance; monitor growth; <span class="nowrap_whitespace">+/–</span> treatment with sex steroids during puberty.</td> <td>Delayed</td> <td>Slow during first 3 to 5 years of life; normal during childhood; pubertal growth spurt is delayed but prolonged, often resulting in normal adult height</td> </tr> <tr> <td class="indent1">SGA infant, with catch-up growth</td> <td>Most SGA infants catch up by 2 years of age; the remainder have slower or absent catch-up growth that can be considered pathologic.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>For prematurely born infants, adjust height for gestational age (up to 1 year of chronologic age)</li> </ul> </td> <td>Monitor growth to distinguish from the 10% of SGA infants who do not have catch-up growth.</td> <td>Normal</td> <td>Normal</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Pathologic causes of growth failure</td> </tr> <tr> <td class="subtitle3_left" colspan="6">Systemic disorders or processes with secondary effects on growth</td> </tr> <tr> <td class="indent2">Undernutrition</td> <td>Low weight-for-height.</td> <td>Hx (including dietary and social Hx), PE, bone age.</td> <td>Reverse nutritional deficit.</td> <td>Delayed or normal</td> <td>Slow (eg, &lt;4 cm/year)</td> </tr> <tr> <td class="indent2">Glucocorticoid therapy</td> <td>Growth effects are dose related, greatest with systemic dosing. Mild effects may occur with long-term use of inhaled glucocorticoids.</td> <td>Hx, PE. <ul class="decimal_heading"> <li>Assess contribution of underlying disease to growth deficit</li> </ul> </td> <td>Minimize glucocorticoid dose or give on alternate days if feasible; consider alternate drugs.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">GI disease (especially Crohn disease and celiac disease)</td> <td>GI symptoms (diarrhea, abdominal pain). Crohn disease may have oral ulcers and anal fissures/skin tags.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>Screening laboratory tests including CBC, ESR or CRP, celiac serologies</li> </ul> </td> <td>Diagnose and treat underlying disease, improve nutrition, avoid glucocorticoids.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">Rheumatologic disease (especially systemic-onset juvenile idiopathic arthritis)</td> <td>Fever, arthralgias, rash, lymphadenopathy.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>Screening laboratory tests including CBC and ESR or CRP, ANA, RF</li> </ul> </td> <td>Diagnose and treat underlying disease, improve nutrition, avoid glucocorticoids.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">Kidney disease (CKD, renal tubular acidosis)</td> <td>Growth impairment may precede the diagnosis of CKD. Other symptoms of CKD may include polyuria, edema, elevated creatinine, tea-colored urine, and hypertension.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>Screening laboratory tests including BUN, creatinine, and urine analysis</li> </ul> </td> <td>Diagnose and treat underlying disease, maximize nutrition; GH if needed.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">Cancer</td> <td> <ul> <li>Any cancer – Multiple mechanisms for growth failure, including decreased intake, increased energy needs</li> <li>Brain cancer – Direct effects on hypothalamic-pituitary function</li> <li>Cancer treated with CNS radiotherapy or chemotherapy – May have direct effects on GH production, with late effects on growth</li> </ul> </td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>For children with history of cancer, or with CNS symptoms or hypothalamic-pituitary disease – Screening laboratory tests to assess pituitary function (free T4, IGF-1, IGFBP-3), <span class="nowrap_whitespace">+/–</span> head MRI with contrast</li> </ul> </td> <td>Ensure adequate nutrition; treat any secondary pituitary hormone deficiencies (eg, GH deficiency).</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">Pulmonary disease (eg, cystic fibrosis, immune deficiencies with recurrent pulmonary infections, or severe asthma)</td> <td>Respiratory symptoms, recurrent infections: <ul class="decimal_heading"> <li>In CF – Steatorrhea/GI symptoms, failure to thrive</li> </ul> </td> <td>Hx, PE, bone age. Test for CF and immune deficiencies.</td> <td>Diagnose and treat underlying disease, ensure adequate nutrition, avoid glucocorticoids.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">Immunologic disease</td> <td>Recurrent infections (manifestations vary depending on type of immunodeficiency).</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>Work-up for immune deficiencies (refer to topic review on children with recurrent infections)</li> </ul> </td> <td>Diagnose and treat underlying disease.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="subtitle3_left" colspan="6">Endocrine causes of growth failure</td> </tr> <tr> <td class="indent2">Hypothyroidism</td> <td>Sluggishness, lethargy, cold intolerance, constipation, decreased reflexes.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>TSH <strong>and</strong> free T4; if hypothyroidism is central (low TSH and low T4), also assess for other pituitary hormone deficiencies.</li> </ul> </td> <td>Thyroid hormone replacement.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">GH deficiency</td> <td>Progressive growth failure. May also have symptoms of other pituitary hormone deficiencies.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>Measurements of GH, IGF-I, and IGFBP-3<sup>¶</sup></li> </ul> </td> <td>rhGH.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">Precocious puberty</td> <td>Virilization.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>LH, FSH<sup>¶</sup></li> </ul> </td> <td>Treatment depends on type of precocious puberty.</td> <td>Advanced</td> <td>Initially fast, then stops early</td> </tr> <tr> <td class="indent2">Cushing syndrome</td> <td>Obesity with central fat distribution; suprascapular fat pad; purple striae.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>24-hour urine collection for free cortisol</li> </ul> </td> <td>Diagnose and treat underlying disease.</td> <td>Delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">Pseudohypoparathyroidism type 1</td> <td>Brachydactyly, short stature, early-onset obesity, ectopic ossifications, sometimes with neurodevelopmental deficits. Resistance to PTH, with or without resistance to TSH and gonadotropins.</td> <td>Hx, PE, bone age. <ul class="decimal_heading"> <li>Serum calcium, phosphate, PTH</li> <li>Molecular genetic testing (<em><a href="https://omim.org/entry/139320" target="_blank">GNAS</a></em> complex locus)</li> </ul> </td> <td>Refer to UpToDate content on treatment of hypocalcemia.</td> <td>Advanced</td> <td>Initially normal or fast, then stops early</td> </tr> <tr> <td class="subtitle3_left" colspan="6">Genetic diseases with primary effects on growth</td> </tr> <tr> <td class="indent2">Turner syndrome</td> <td> <p>Square "shield" chest, webbed neck, cubitus valgus<sup>Δ</sup>, genu valgum, Madelung deformity<sup>◊</sup>.</p> Up to 50% have only short stature and absent pubertal development.</td> <td>Karyotype analysis (for 45,X, structural abnormality of X, or mosaic).</td> <td>Estrogen, GH.</td> <td>Normal</td> <td>Slow</td> </tr> <tr> <td class="indent2">SHOX mutations</td> <td>May have isolated short stature (usually stocky appearance) <strong>or</strong> additional features: shorter forearms and lower legs, cubitus valgus<sup>Δ</sup>, Madelung deformity<sup>◊</sup>, high-arched palate.</td> <td>Molecular genetic testing for <em><a href="https://omim.org/entry/312865" target="_blank">SHOX</a></em> abnormalities.</td> <td>Consider GH.</td> <td>Normal</td> <td>Slow</td> </tr> <tr> <td class="indent2">Noonan syndrome</td> <td>Minor facial dysmorphism, heart disease, intellectual disability, webbed neck, pectus excavatum, cryptorchidism.</td> <td>Molecular genetic testing for <em><a href="https://omim.org/entry/176876" target="_blank">PTPN11</a></em>, <em><a href="https://omim.org/entry/182530" target="_blank">SOS1</a></em>, and <a href="https://omim.org/entry/163950" target="_blank">other genes</a><sup>¶</sup>.</td> <td>Consider GH.</td> <td>Normal</td> <td>Low-normal or slow</td> </tr> <tr> <td class="indent2">Silver-Russell syndrome</td> <td>Severe intrauterine growth restriction and postnatal growth retardation. Prominent forehead, triangular face, downturned corners of the mouth, and body asymmetry (hemihypertrophy).</td> <td>Clinical diagnosis, supported by molecular genetic testing<sup>¶</sup>.</td> <td>Consider GH.</td> <td>Normal</td> <td>Slow</td> </tr> <tr> <td class="subtitle3_left" colspan="6">Skeletal dysplasias</td> </tr> <tr> <td class="indent2">Achondroplasia</td> <td>Short arms and legs, midface hypoplasia, trident hands. Most cases identified prenatally or in early infancy.</td> <td>Clinical diagnosis. <ul class="decimal_heading"> <li>Genetic testing for <em><a href="https://omim.org/entry/134934" target="_blank">FGFR3</a></em> gene mutations is available<sup>¶</sup></li> </ul> </td> <td>Management of complications, which may include craniocervical junction compression, sleep apnea, spinal stenosis.</td> <td>Mildly delayed</td> <td>Slow</td> </tr> <tr> <td class="indent2">Hypochondroplasia</td> <td>Short arms and legs similar to but milder than in achondroplasia; lumbar lordosis. May include macrocephaly, epilepsy.</td> <td>Skeletal survey. <ul class="decimal_heading"> <li>Genetic testing for <em><a href="https://omim.org/entry/134934" target="_blank">FGFR3</a></em> gene mutations (positive in 70%)</li> </ul> </td> <td>Surveillance for spinal stenosis, with surgery as needed.</td> <td>? Normal</td> <td>Slow</td> </tr> <tr> <td class="indent2">Spondyloepiphyseal dysplasia</td> <td>Heterogeneous manifestations; trunk disproportionately shortened compared with limbs; may develop scoliosis, kyphosis, and osteoarthritis.</td> <td>Anthropometrics; skeletal survey.</td> <td>Surveillance for spinal disorders and osteoarthritis, with surgery as needed.</td> <td>? Normal</td> <td>Slow</td> </tr> <tr> <td class="indent2">Osteogenesis imperfecta</td> <td>Children with moderate to severe disease are usually recognized by recurrent fractures but also develop short stature. Blue sclerae, scoliosis, and hearing loss may be present.</td> <td>Skeletal survey.</td> <td>Bisphosphonates, fracture management.</td> <td>Normal</td> <td>Low-normal or slow</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>ANA: antinuclear antibodies; 
        BUN: blood urea nitrogen; 
        CBC: complete blood count; 
        CF: cystic fibrosis; 
        CKD: chronic kidney disease; 
        CNS: central nervous system; 
        CRP: C-reactive protein; 
        ESR: erythrocyte sedimentation rate; 
        FSH: follicle-stimulating hormone; 
        GH: growth hormone; 
        GI: gastrointestinal; 
        Hx: history; 
        IGF-1: insulin-like growth factor 1; 
        IGFBP-3: insulin-like growth factor binding protein 3; 
        LH: luteinizing hormone; 
        MRI: magnetic resonance imaging; 
        PE: physical examination; 
        PTH: parathyroid hormone; 
        RF: rheumatoid factor; 
        rhGH: recombinant human growth hormone; 
        SGA: small for gestational age; 
        T4: thyroid hormone; 
        TSH: thyroid-stimulating hormone.</p>
<p>* Some patients have features of both familial short stature and constitutional delay of growth and puberty.</p>
<p>¶ Evaluation of patients in whom this disorder is suspected usually is performed by a subspecialist (ie, a pediatric endocrinologist, gastroenterologist, or geneticist).</p>
<p>Δ Cubitus valgus is an increased carrying angle of the arm.</p>
    
    ◊ Madelung deformity is focal dysplasia of the distal radial physis, which can result in a prominent ulna and wrist pain.</div><div id="graphicVersion">Graphic 94176 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
